Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-fosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): A FONICAP randomized phase II study

British Journal of Cancer

Volumn 77, Issue 12, 1998, Pages 2367-2370

  Baldini, E ^a   Tibaldi, C ^a   Ardizzoni, A ^a   Salvati, F ^a   Antilli, A ^a   Portalone, L ^a   Barbera, S ^a   Romano, F ^a   De Marinis, F ^a   Migliorino, M R ^a   Noseda, M A ^a   Borghini, U ^a   Crippa, M ^a   Ferrara, G ^a   Raimondi, M ^a   Fioretti, M ^a   Bandera, M ^a   Pennucci, M C ^a   Galeasso, G ^a   Cacciani, G C ^a   Lepidini, G ^a   Sunseri, G ^a   Lanfranco, C ^a   Rinaldi, M ^a   Lionetto, R ^a   Conte, P F ^a   Rosso, R ^a   more..

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Advanced non small cell lung cancer; Platinum based chemotherapy; Randomized phase II study

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; IFOSFAMIDE; MITOMYCIN; NAVELBINE; VINDESINE;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031745011     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.393     Document Type: Article

References (18)